SON-1010
Sonnet BioTherapeutics
[]
$sonn sonnet biotherapeutics announces webcast to discuss clinical data from the sb101 study with son-1010 being presented at the aacr 2023 annual meeting 45 seconds delayed.
Democratizing insights.

Not investment advice.